ALLURION TECHNOLOGIES, INC.

Allurion Technologies, LLC (formerly Allurion Technologies Opco, Inc., which was previously Allurion Technologies, Inc., a Delaware corporation formed in 2009, and sometimes referred to as Legacy Allurion) and its subsidiaries, and after the Business Combination, Allurion (formerly Allurion Technologies Holdings, Inc., a Delaware corporation formed in 2023) and its subsidiaries, focuses on metabolically healthy weight loss. The company's platform, the Allurion Program, includes the Allurion Smart Capsule, which is the world's first and only swallowable, Procedureless intragastric balloon for weight loss. The program also provides access to AI-powered remote patient monitoring tools, a proprietary behavior change program, and secure messaging and video telehealth through the Allurion Virtual Care Suite (VCS). Over 200,000 patients have been treated commercially with the Allurion Smart Capsule in over 50 countries outside of the United States. The Allurion Program aims to achieve weight loss, maintain that weight loss, and maintain or increase muscle mass. The Allurion Smart Capsule is swallowed as a capsule under healthcare provider guidance, without surgery, endoscopy, or anesthesia, with placement taking approximately 15 minutes during an outpatient visit.